P1362In patients with end stage functional mitral regurgitation, mitral annulus geometry is independent on the ischemic or non-ischemic etiology of left ventricular dysfunction [PDF]
Patrizia Aruta +14 more
openalex +1 more source
Spotlight commentary—Insulin therapy: Future directions
British Journal of Clinical Pharmacology, EarlyView.
Ana Deškin +4 more
wiley +1 more source
ABSTRACT Coronary slow flow (SF) and no‐reflow (NR) are clinically significant complications of percutaneous coronary intervention (PCI), particularly in ST‐segment elevation myocardial infarction (STEMI) and saphenous vein graft (SVG) interventions. Angiographically defined as impaired myocardial perfusion despite restored epicardial patency, SF/NR ...
Bharat Khialani +5 more
wiley +1 more source
Plasma Level of Stromal Cell-Derived Factor-1 Provides Insight Into Statin Response, But Not Into Left Ventricular Dysfunction in New Unstable Angina. [PDF]
Murad H, Qutub M.
europepmc +1 more source
Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub‐Study
ABSTRACT Background Physical decline after transcatheter aortic valve implantation (TAVI) is associated with worse outcomes. However, data on post‐TAVI extremity function are limited. This sub‐study of the TAVI XS trial aimed to assess extremity function after transfemoral TAVI, evaluate functional decline, compare outcomes between upper‐and lower ...
Geert A. A. Versteeg +20 more
wiley +1 more source
Artificial Intelligence for Detection of Prognostically Significant Left Ventricular Dysfunction From Echocardiography. [PDF]
Playford D +5 more
europepmc +1 more source
Levosimendan Improves Hemodynamic Status in Critically Ill Patients with Severe Aortic Stenosis and Left Ventricular Dysfunction: An Interventional Study [PDF]
Martín J. García‐González +5 more
openalex +1 more source
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park +22 more
wiley +1 more source

